GLP-1 Weight Loss Clinics in Memphis, Tennessee

Browse 21 GLP-1 clinics in Memphis offering semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and medically-supervised weight loss programs. Compare pricing, insurance, and physician credentials before you book.

21 clinics in Memphis, TN

Browse all

Own a GLP-1 clinic in Memphis?

Claim your free listing or add your clinic to reach patients actively searching in Memphis.

Add Your Clinic — Free

GLP-1 Clinics in Memphis — FAQ

How many GLP-1 clinics are in Memphis?
FindGLP1Clinic.com lists 21 GLP-1 weight loss clinics in Memphis, Tennessee. This includes physician-supervised programs, med spas offering semaglutide, and telehealth providers that serve the area. New clinics are added weekly.
How much does semaglutide cost in Memphis?
GLP-1 treatment in Memphis typically costs $150–$600 per month. Brand-name Wegovy and Ozempic are on the higher end ($800–$1,300/month without insurance). Compounded semaglutide — available at many Memphis clinics — runs $150–$350/month. Many clinics bundle the initial consultation into the first month's cost.
Does insurance cover Ozempic or Wegovy in Tennessee?
Coverage varies. Some commercial plans cover Wegovy for obesity (BMI ≥30 or ≥27 with a comorbidity) when prescribed by a physician. Ozempic is primarily covered for type 2 diabetes — weight loss coverage is narrower. Tennessee Medicaid coverage depends on your specific plan. The best way to know: call the clinics that list "Insurance Accepted" and ask them to verify your specific plan.
Can I start GLP-1 treatment via telehealth in Memphis?
Yes — several GLP-1 providers serving Memphis offer fully virtual consultations. You can get a prescription for semaglutide or tirzepatide without an in-person visit, with medication shipped directly to you. Look for the Telehealth badge on listings above. Note: some telehealth providers don't accept insurance, so compare options carefully.
What's the difference between semaglutide and tirzepatide?
Both are GLP-1 receptor agonists that reduce appetite and promote weight loss. Semaglutide (Wegovy, Ozempic) targets the GLP-1 receptor only. Tirzepatide (Mounjaro, Zepbound) targets both GLP-1 and GIP receptors, which tends to produce slightly more weight loss on average (around 20–22% vs. 14–16% for semaglutide). Cost and insurance coverage differ — tirzepatide is newer and often harder to get covered.